Health Care: Drugs

Sarepta Therapeutics Inc (SRPT: NASDAQ)

$16.61 0.88 | 5.59%
11/24/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 15.73
52 Week High 40.00
52 Week Low 14.31
Avg. Daily Vol. (Mil) 1.65
Beta (3 year) 1.68
Share Related Items
Mkt Cap (Mil) 649.81
Shares Out (Mil) 41.31
Float (Mil) 37.89
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.50
Current Ratio 11.90
LT Debt/ Equity 0.01
Total Debt / Equity 0.02
Valuation Ratios
Price Earnings n.a.
Price/Sales 52.59
Price/Book 2.27
Price/Cash Flow -6.80
Per Share Data
Earnings -2.45
Sales 0.30
Book Value 6.93
Cash Flow -2.31
Business Summary
Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
General Information
215 First Street
Suite 415
Cambridge, MA 02142
www.sareptatherapeutics.com
Industry : Drugs
Sector: Health Care
Employees: 146
CEO: Mr. Christopher Garabedi
Short Interest
Current Month (Mil) 13.59
Previous Month (Mil) 12.92
Short Interest Ratio (Days) 5.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -31.40
Return on Investments -34.60
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with SRPT

Latest SRPT Headlines from TheStreet

More Financial News for SRPT

Press Releases for SRPT

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter